{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": 6.8181844, "regularMarketPrice": 0.282, "exchange": "FRA", "shortName": "ELICERA THERAPEUTICS AB", "longName": "Elicera Therapeutics AB (publ)", "messageBoardId": "finmb_699501886", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683892037, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.08, "sharesOutstanding": 19782000, "fiftyDayAverage": 0.28724, "fiftyDayAverageChange": -0.0052399933, "fiftyDayAverageChangePercent": -0.018242562, "twoHundredDayAverage": 0.3242475, "twoHundredDayAverageChange": -0.042247504, "twoHundredDayAverageChangePercent": -0.130294, "marketCap": 6610390, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Elicera Therapeutics AB", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1625032800000, "priceHint": 4, "regularMarketChange": 0.018000007, "regularMarketDayHigh": 0.282, "regularMarketDayRange": "0.261 - 0.282", "regularMarketDayLow": 0.261, "regularMarketVolume": 4600, "regularMarketPreviousClose": 0.264, "bid": 0.261, "ask": 0.362, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.261, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.029000014, "fiftyTwoWeekLowChangePercent": 0.11462457, "fiftyTwoWeekRange": "0.253 - 0.43", "fiftyTwoWeekHighChange": -0.148, "fiftyTwoWeekHighChangePercent": -0.34418604, "fiftyTwoWeekLow": 0.253, "fiftyTwoWeekHigh": 0.43, "symbol": "8E8.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "World Trade Centre Gothenburg", "address2": "Floor 7 M\u00e4ssans gata 10", "city": "Gothenburg", "zip": "412 51", "country": "Sweden", "phone": "46 7 03 31 90 51", "website": "https://www.elicera.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Elicera Therapeutics AB (publ), a clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden. The company's portfolio products in pipeline includes ELC-100, a Phase I/II drug candidate for neuroendocrine tumors indications; ELC-201, a preclinical drug candidate for the treatment of various injectable solid tumors; ELC-301, a CAR T-cell therapy for the treatment of Non-Hodgkin's B-cell lymphoma; and ELC-401, a preclinical drug candidate glioblastoma multiforme (brain tumor) indications. It also develops iTANK, a technology platform used to optimize the effect of various CAR T-cell therapies for the multi-targeted attack on solid tumors. The company was incorporated in 2014 and is based in Gothenburg, Sweden.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jamal  El-Mosleh M.Sc.", "age": 41, "title": "CEO & Co-Founder", "yearBorn": 1981, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Magnus  Essand", "age": 58, "title": "Chief Science Officer, Co-Founder & Director", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Di  Yu", "age": 37, "title": "Co-Founder and Head of Transitional Research & Technical Operations", "yearBorn": 1985, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ingvar  Karlsson", "age": 66, "title": "Chief Financial Officer", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Anna Koptina Gultekin", "title": "Head of Regulatory Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}